Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corneal epithelial cell therapy
- Development stage
- Unknown
- Lead developer
- GN Corporation
- Modality
- Cell Therapies
- Administration
- Ophthalmic
01
Overview
Corneal epithelial cell therapy is a regenerative medicine approach being developed by GN Corporation in collaboration with the Nichi In Centre for Regenerative Medicine (NCRM). The therapy involves the transplantation or delivery of corneal epithelial cells to the ocular surface to treat epithelial defects and restore the integrity of the corneal surface. This cell-based intervention aims to address various corneal epithelial diseases by regenerating the outermost layer of the cornea, potentially utilizing tissue engineering techniques and specialized scaffolds to support cell graft survival and integration. The program is currently in early clinical development, targeting patients with compromised corneal surface integrity.
- Other names
- Corneal epithelial cell therapy
Beyond the preview
Go deeper on Corneal epithelial cell therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corneal epithelial cell therapy.